NOOSPHERE

Fichas públicas de documentos

Referencias bibliográficas de procedencia pública y con enlaces estables. El catálogo no incluye todos los documentos del corpus ni reproduce sus textos completos.

98,186 fichas públicas · página 13 / 982

  1. Bradycardia, rare extreme QT prolongation and Giant inverted T waves following Grayanotoxin (mad honey) intoxication: A short communication and literature review.2026 · PubMed
  2. Brain activity and the production of written text during mediumistic trance: A controlled EEG study2026 · OpenAlex
  3. Brain functional network correlates and predictors of the perioperative antidepressant effect of esketamine in breast cancer patients: a double-blind randomized controlled trial using resting-state fMRI and graph theory2026 · OpenAlex
  4. Brain iron-sensitive markers (magnetic susceptibility and R2*) predict antidepressant response to ketamine in treatment-resistant depression.2026 · PubMed
  5. Brain network alterations underlying cue reactivity and craving in abstinent methamphetamine users: a systematic review of functional MRI findings.2026 · PubMed
  6. Brain Network Convergence of Abnormal Gray Matter and Functional Activity of Pathological Dissociative Symptoms2026 · OpenAlex
  7. Brain region-specific and sex-dependent roles of 2-arachidonoylglycerol in the retrieval of contextual fear memory in mice.2026 · PubMed
  8. Brain white matter microstructural integrity differences between pre-post buprenorphine-naloxone treated individuals with opioid use disorder: Evidence from a DTI study.2026 · PubMed
  9. Brain-body integromics of the ayahuasca experience.2026 · PubMed
  10. Brain-targeted epigenetic effects of two emerging psychoplastogens: ketamine & MDMA.2026 · PubMed
  11. Brain-wide reconfiguration of burst firing by psilocybin reveals 5-HT2A-dependent circuit dynamics2026 · OpenAlex
  12. Brand Sharing and New Drinking Occasions: A Content Analysis of How Alcohol Brands in Australia and Aotearoa New Zealand Promote Zero Alcohol Products2026 · Crossref
  13. BRANDING STRATEGIES AND COMPETITIVE ADVANTAGE OF MICRO AND SMALL COFFEE ENTERPRISES: A QUALITATIVE CASE STUDY OF 360 COFFEE IN INDONESIA2026 · Crossref
  14. Branding Strategies for Coffee Products Based on Local Terroir: A Case Study of Argotirto Coffee2026 · Crossref
  15. Breaking psychedelic boundaries in public health: emerging ideas with ancient roots2026 · OpenAlex
  16. Breathwork Interventions for Substance Use Disorders: Systematic Search Strategy (PubMed).2026 · OpenAlex
  17. Bridging ethnobotany and neuro-pharmacology: exploring South Africa’s indigenous plants for brain health2026 · Crossref
  18. Bridging Gaps in Care: Evaluation of a Mobile Health Model Addressing Social Determinants and Harm Reduction in Eastern Puerto Rico2026 · Crossref
  19. Bridging genomics and pharmacoepidemiology to expand treatment options for alcohol use disorder2026 · Crossref
  20. Bridging Safety and Compliance: The Dual Role of Ion-Exchange Resins in Pediatrics and Abuse-Deterrent Drug Delivery2026 · Crossref
  21. Bridging the gap between policy and practice: a mixed-methods study of tobacco control implementation challenges and community responses in Hyderabad, Sindh, Pakistan2026 · Crossref
  22. Bridging the Gap: A Secondary Data Analysis of Implementation Outcomes and Symptom Trajectories of an eHealth Mental Health and Parenting Treatment Among Mothers With and Without At-Risk Substance Use2026 · Crossref
  23. Bridging the Gap: Neurocircuitry Behind Mutism: Insights From a Midbrain Lesion.2026 · PubMed
  24. Bridging the gaps for women in substance use treatment2026 · Crossref
  25. Bridging Traditional Knowledge and Modern Research: A Comprehensive Review of Four Medicinal Plants from Uttarakhand, India2026 · Crossref
  26. Bridging veteran psychedelic peer expertise with research and clinical care: Peer Readiness and Education for Psychedelic Practice (PREPP) workshop2026 · OpenAlex
  27. Brief report: Ketamine‐assisted “bridge therapy” for opioid tapering in complex cases2026 · OpenAlex
  28. Brief report: Meth, tranq, gas station heroin & other drugs complicating addiction treatment.2026 · PubMed
  29. Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World Implementation.2026 · PubMed
  30. Broad-spectrum LC-MS/MS hair analysis for monitoring recreational drug use in electronic dance music festival attendees.2026 · PubMed
  31. Bromazolam Tablet Quantification and Analysis of Post‐Mortem Cases From the National Programme on Substance Use Mortality (NPSUM)2026 · Crossref
  32. Brorphine and Its Analogues: Pharmacology, Toxicology, and Biomonitoring.2026 · PubMed
  33. Broussochalcone A alleviates cognitive impairment in scopolamine-induced mice as a potent β-amyloid aggregation inhibitor and changes blood and brain metabolite profiles.2026 · PubMed
  34. BRUGMANSIA ARBOREA (FLORIPONDIO): REVISIÓN ETNOFARMACOLÓGICA Y ANÁLISIS DE INVESTIGACIONES BIOMÉDICAS RECIENTES2026 · OpenAlex
  35. Budtender Perspectives on the Cannabis Retail System’s Capacity to Support Customers with Mental Health Concerns: A Qualitative Study2026 · Crossref
  36. BUILDING A PEER SUPPORT NETWORK FOR DRUG ADDICTION RECOVERY IN MALAYSIA Authors2026 · Crossref
  37. Building a Resilient Substance Use Disorder Treatment Safety Net in An Era of Austerity: Challenges for US State Governments2026 · Crossref
  38. Building a Rural, Coalition-Based Approach to Youth Substance Use Prevention: The Drug Free Dickson Coalition Model2026 · Crossref
  39. Building Community Capacity for Harm Reduction: An Adaptive Implementation Science Approach in Rural Appalachian Ohio2026 · Crossref
  40. Building people back better: A harm reduction framework for Indigenous emergency management2026 · Crossref
  41. Building Stronger Communities Through Addiction Care Innovation, Research, Education, and Advocacy-Overview and Proceedings of the AMERSA 2025 Conference.2026 · PubMed
  42. Building the bridge-back: Dissociation as resource and resilience pathway in psychedelic-assisted therapy2026 · Crossref
  43. Bullying and Drug Use as Methods of Deviant Self-Affirmation among Students of Cadet Classes and Corps2026 · Crossref
  44. Buprenorphine following ketamine treatment enhances anti‐suicidal effects2026 · Crossref
  45. Buprenorphine for the Management of 7-Hydroxymitragynine (7-OH) Use: A Retrospective Case Series.2026 · PubMed
  46. Buprenorphine long acting injectables: clinical needs, pharmacodynamic and pharmacokinetic basis, and design challenges for solid preformed implants.2026 · PubMed
  47. Buprenorphine Oral Lyophilisate for Treatment of Opioid Use Disorder: Pharmacology and Clinical Efficacy2026 · Crossref
  48. Buprenorphine prescribing is increasingly delivered by primary care nurse practitioners to Medicaid beneficiaries.2026 · PubMed
  49. Buprenorphine Use and the Risk of Dental Adverse Events in Patients With Opioid Use Disorder2026 · Crossref
  50. Bupropion‐Memantine Combination in the Treatment of Major Depressive Disorder and Treatment‐Resistant Depression2026 · Crossref
  51. Burden of cardiovascular disease in victims of fatal intoxication: An autopsy study.2026 · PubMed
  52. Burnout and coping among professionals working in a drug consumption room: a qualitative study2026 · Crossref
  53. Business and Service Provider Attitudes Towards Police Involvement in Overdose Response: A Cross-Sectional Survey in Rhode Island Overdose Hotspots.2026 · PubMed
  54. BUSINESS DEVELOPMENT PLAN FOR COFFEE TRAINING AT CH3FFEIN COFFEE RESEARCH AND DEVELOPMENT UNIT2026 · Crossref
  55. Business Development Strategy through Product Diversification and Store Atmosphere to Increase Sales Volume of Renjana Coffee Shop2026 · Crossref
  56. Business Practices, Performance, and Challenges in the Retail Cannabis Industry2026 · Crossref
  57. Business pressures, policy shifts weigh on LGBTQ+ program advocates2026 · Crossref
  58. C29-12 Psilocybin Treatment Could Improve Outcomes for Age-associated Lung Diseases2026 · Crossref
  59. C44-04 Not Everything Wheezes Is Asthma: Recurrent Betel-Nut Aspiration Mimicking Endobronchial Malignancy2026 · Crossref
  60. C53-28 Kratom Kills: Mitragyna Speciosa Induced Multi-system Organ Failure and Death2026 · Crossref
  61. C53-35 Stopped Drinking Alcohol but Started Sniffing Isopropanol2026 · Crossref
  62. C57BL/6N mutation in cytoplasmic FMRP interacting protein 2 regulates nicotine reward in the conditioned place preference test2026 · Crossref
  63. Caffeine Consumption Patterns and Awareness Among Pharmacy Undergraduate Students: A Case Study from IMT Pharmacy College, Odisha2026 · Crossref
  64. Caffeine in Forensic Toxicology: A Comprehensive Review of Sources, Pharmacokinetics, Analytical Methods, and Medico-Legal Implications2026 · Crossref
  65. Caffeine makes a splash: a systematic review and multilevel meta-analysis exploring the effects of caffeine intake on swimming performance.2026 · PubMed
  66. Caffeine-induced ego-confrontation during rest2026 · OpenAlex
  67. Calcium activation mechanism of a noncanonical aromatic L-amino acid decarboxylase from psilocybin mushroom Psilocybe cubensis2026 · Crossref
  68. California’s prohibition of flavoured tobacco sales and the tobacco industry’s attempts to evade it2026 · Crossref
  69. Callus Induction from Anthers of Cannabis sativa2026 · Crossref
  70. Campaneando : Surveilling With the Dead in Bogotá’s Drug Markets2026 · Crossref
  71. Can dead bodies do politics? Decolonising Rancière through the Philippine drug war2026 · Crossref
  72. Can the incentive-sensitization theory of addiction incorporate addiction to opioid drugs?2026 · Crossref
  73. Canadian taxation methods for cannabis: an examination of the impact of different tax methods based on legal products sold in Ontario2026 · Crossref
  74. Cancer Council’s Tackling Tobacco program: an Australian initative building partnerships for public health research impact2026 · Crossref
  75. Cancer-related pain: A bidirectional modulator of cancer progression.2026 · PubMed
  76. Candidate Biomarkers of Bipolar Disorder Progression: Implications for Ketamine and Psychedelic Interventions.2026 · PubMed
  77. Cang-Ai Volatile Oil Ameliorates Chronic Unpredictable Mild Stress-Induced Depression-like Symptoms in Rats by Regulating NT/Trk Signaling Pathway.2026 · PubMed
  78. Cannabichromene (CBC): a comprehensive review of biosynthesis, pharmacology, therapeutic potential, and translational perspectives2026 · Crossref
  79. Cannabidiol alleviates chemotherapy-induced cognitive decline and neuropathology.2026 · PubMed
  80. Cannabidiol and Cancer Survivors: Utilization and Experiences.2026 · PubMed
  81. CANNABIDIOL AND MEDICAL CANNABIS IN BRAZIL: WHAT PHYSICIANS NEED TO KNOW2026 · Crossref
  82. Cannabidiol and other non-psychotropic cannabinoids from Cannabis sativa as therapeutics for microglial-mediated neuroinflammation and neurodegeneration2026 · Crossref
  83. Cannabidiol and Δ<sup>9</sup>-tetrahydrocannabinol alter human hematopoiesis by enhancing B cell lineage commitment.2026 · PubMed
  84. Cannabidiol corrects sleep deficits and reduces spontaneous seizures in Angelman syndrome model mice.2026 · PubMed
  85. Cannabidiol in Food and Food Supplements: Drug, Novel Food and Hazard Triangle2026 · OpenAlex
  86. Cannabidiol lymphatic transport after oral administration assessed using a novel thoracic lymph duct cannulated conscious pig model.2026 · PubMed
  87. Cannabidiol modulates classical and non-classical HLA expression in human choriocarcinoma cell line.2026 · PubMed
  88. Cannabidiol selectively downregulates FAM111B expression and induces apoptosis in fibrosarcoma cells: an in vitro study2026 · Crossref
  89. Cannabidiol-Dominant Cannabis sativa L. Inflorescence Extract Ameliorates Atopic Dermatitis by Modulating NLRP3 Inflammasome and JAK1/STAT6 Signaling in DNCB-Induced Mice2026 · Crossref
  90. Cannabidiol-thiosemicarbazone exhibits dual tyrosinase inhibition and antioxidant activity in human skin-derived cells.2026 · PubMed
  91. Cannabidiolic acid causes a defect in tail retraction of migrating MDA-MB-231 cells: possible involvements of Rho-associated protein kinases inhibition and accumulation of vinculin at the rear of migrating cells.2026 · PubMed
  92. Cannabigerol and cannabidiol differ in their ability to affect the AhR/CYP1A pathway in vitro.2026 · PubMed
  93. Cannabinoid exposure across substance use disorders: Short-term symptom benefits without sustained therapeutic gains in a tier-weighted systematic review.2026 · PubMed
  94. Cannabinoid hyperemesis syndrome from delta-8 tetrahydrocannabinol after discontinuing regular cannabis use2026 · Crossref
  95. Cannabinoid Hyperemesis Syndrome-A Survey-Based Approach to Understanding Symptoms and Cannabis Use Patterns2026 · Crossref
  96. Cannabinoid modulation of central amygdala population dynamics during threat investigation.2026 · PubMed
  97. Cannabinoid Positivity in Traffic Fatalities Before and After Cannabinoid Legalization: A Retrospective Analysis in Connecticut (2018-2024).2026 · PubMed
  98. Cannabinoid therapeutics in the 21st century: from molecular mechanisms to equitable clinical integration2026 · OpenAlex
  99. Cannabinoid type 1 receptor availability imaging in attention-deficit/hyperactivity disorder using [<sup>18</sup>F]MK-9470 positron emission tomography: study protocol of the CB1-ADHD study.2026 · PubMed
  100. Cannabinoids and Terpenoids in Hemp Inflorescence and Leaves of Three Varieties in Yunnan China.2026 · PubMed